{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T22:35:15Z","timestamp":1784673315501,"version":"3.55.0"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T00:00:00Z","timestamp":1677196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Drug Saf. Regul."],"abstract":"<jats:p>Medical devices made of substances (MDMS) have recently gained great popularity in several specialties of internal medicine, including gastroenterology. In the last decades this discipline has known relevant advances in the cure of severe diseases, such as peptic ulcer, gastroesophageal reflux disease and chronic hepatitis C, thanks to the revolutionary development of new drugs able to act on single receptors changing a particular cell function or blocking microbial and viral replication. However, there are many gastroenterological illnesses that are difficult to treat with traditional medicinal products because of their complex and poorly known pathophysiology, which comprises altered motility, visceral hypersensitivity, gut dysbiosis, intestinal mild inflammation with impaired immune function, increased mucosal permeability and abnormal brain-gut interaction. They are mainly represented by esophageal functional disorders (reflux hypersensitivity, functional heartburn), functional dyspepsia, irritable bowel syndrome, functional constipation and functional diarrhea. Traditional drugs do not provide a definitive resolution of these disorders with a multifactorial pathogenesis and they can benefit from the use of MDMS, which seem to have the ability to act on different factors thanks to the synergistic action of their various components. International medical literature already reports many clinical trials performed with the well-known standards for evaluating their efficacy and safety in a great part of the above-mentioned conditions.<\/jats:p>","DOI":"10.3389\/fdsfr.2023.1119353","type":"journal-article","created":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T01:57:33Z","timestamp":1677203853000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Gastrointestinal functional disorders can benefit from the use of medical devices made of substances"],"prefix":"10.3389","volume":"3","author":[{"given":"Vincenzo","family":"Savarino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Marabotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Zentilin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuele","family":"Furnari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Bodini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Giovanni Giannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo Vincenzo","family":"Savarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1111\/apt.16295","article-title":"Review article: Potassium-competitive acid blockers for the treatment of acid-related disorders","volume":"53","author":"Abdel-Aziz","year":"2021","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B2","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1365-2036.1994.tb00313.x","article-title":"Clarithromycin-amoxycillin therapy for Helicobacter pylori infection","volume":"8","author":"al-Assi","year":"1994","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B3","doi-asserted-by":"publisher","first-page":"136800178","DOI":"10.1053\/j.gastro.2016.02.012","article-title":"Esophageal disorders","volume":"150","author":"Aziz","year":"2016","journal-title":"Gastroenterology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3109\/00365529609094548","article-title":"Italian omeprazole triple therapy--a 1-week regimen","volume":"215","author":"Bazzoli","year":"1996","journal-title":"Scand. J. Gastroenterol. Suppl."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1055\/a-1511-8558","article-title":"Medical devices made of substances: Possible innovation and opportunities for complex natural products","volume":"87","author":"Bilia","year":"2021","journal-title":"Planta Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/236385a0","article-title":"Definition and antagonism of histamine H 2 -receptors","volume":"236","author":"Black","year":"1972","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1056\/NEJM199812243392602","article-title":"Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus clarithromycin and amoxicillin effect one year after treatment (OCAY) study group","volume":"339","author":"Blum","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e00021","DOI":"10.14309\/ctg.0000000000000021","article-title":"A novel, duodenal-release formulation of a combination of caraway oil and L-menthol for the treatment of functional dyspepsia: A randomized controlled trial","volume":"10","author":"Chey","year":"2019","journal-title":"Clin. Transl. Gastroenterol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"397","DOI":"10.7326\/M14-1336","article-title":"Cost-effectiveness and budget impact of hepatitis C virus treatment with sofosbuvir and ledipasvir in the United States","volume":"162","author":"Chhatwal","year":"2015","journal-title":"Ann. Intern Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2147\/CEG.S31404","article-title":"Barrier effect of Esoxx(\u00ae) on esophageal mucosal damage: Experimental study on ex-vivo swine model","volume":"5","author":"Di Simone","year":"2012","journal-title":"Clin. Exp. Gastroenterol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"126200223","DOI":"10.1053\/j.gastro.2016.02.032","article-title":"Functional gastrointestinal disorders: History, pathophysiology, clinical features and Rome IV","volume":"150","author":"Drossman","year":"2016","journal-title":"Gastroenterology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41572-021-00287-w","article-title":"Gastro-oesophageal reflux disease","volume":"7","author":"Fass","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B13","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nrgastro.2013.96","article-title":"Helicobacter pylori research: Historical insights and future directions","volume":"10","author":"Fock","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"S132","DOI":"10.1016\/j.jhep.2014.09.019","article-title":"Simplification of antiviral hepatitis C virus therapy to support expanded access in resource-limited settings","volume":"61","author":"Ford","year":"2014","journal-title":"J. Hepatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1056\/NEJMc1601160","article-title":"Sofosbuvir and velpatasvir for patients with HCV infection","volume":"374","author":"Foster","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"CD009118","DOI":"10.1002\/14651858.CD009118.pub3","article-title":"Osmotic and stimulant laxatives for the management of childhood constipation","volume":"2016","author":"Gordon","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"B17","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1097\/01.psy.0000075977.90337.e7","article-title":"Medically unexplained physical symptoms, anxiety, and depression: A meta-analytic review","volume":"65","author":"Henningsen","year":"2003","journal-title":"Psychosom. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1053\/gast.1996.v110.pm8613015","article-title":"Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: A review","volume":"110","author":"Hopkins","year":"1996","journal-title":"Gastroenterology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3350\/cmh.2020.0018","article-title":"Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy","volume":"26","author":"Huang","year":"2020","journal-title":"Clin. Mol. Hepatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/0016-5085(88)90319-8","article-title":"Controlled treatment trials in the irritable bowel syndrome: A critique","volume":"95","author":"Klein","year":"1988","journal-title":"Gastroenterology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"CD007570","DOI":"10.1002\/14651858.CD007570.pub2","article-title":"Lactulose versus polyethylene glycol for chronic constipation","author":"Lee-Robichaud","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","article-title":"Functional bowel disorders","volume":"130","author":"Longstreth","year":"2006","journal-title":"Gastroenterology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1136\/gutjnl-2022-327745","article-title":"European Helicobacter and microbiota study group. Management of Helicobacter pylori infection: The maastricht VI\/florence consensus report","volume":"71","author":"Malfertheiner","year":"2022","journal-title":"Gut"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1080\/14656566.2017.1346087","article-title":"Vonoprazan fumarate for the management of acid-related diseases","volume":"18","author":"Martinucci","year":"2017","journal-title":"Expert Opin. Pharmacother."},{"key":"B25","doi-asserted-by":"publisher","first-page":"139300222","DOI":"10.1053\/j.gastro.2016.02.031","article-title":"Bowel disorders","volume":"150","author":"Mearin","year":"2016","journal-title":"Gastroenterology"},{"key":"B26","first-page":"S49","article-title":"Rationale for the choice of antibiotics for the eradication of Helicobacter pylori","volume":"7","author":"M\u00e9graud","year":"1995","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"790","DOI":"10.17235\/reed.2016.4571\/2016","article-title":"Use of polyethylene glycol in functional constipation and fecal impaction","volume":"108","author":"M\u00ednguez","year":"2016","journal-title":"Rev. Esp. Enferm. Dig."},{"key":"B28","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nrgastro.2013.222","article-title":"Hepatitis C in 2013: HCV causes systemic disorders that can be cured","volume":"11","author":"Negro","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B29","first-page":"3272","article-title":"Fixed combination of hyaluronic acid and chondroitin-sulphate oral formulation in a randomized double blind, placebo controlled study for the treatment of symptoms in patients with non-erosive gastroesophageal reflux","volume":"17","author":"Palmieri","year":"2013","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.3390\/jcm11071890","article-title":"The effect of hyaluronic acid and chondroitin sulphate-based medical device combined with acid suppression in the treatment of atypical symptoms in gastroesophageal reflux disease","volume":"11","author":"Pellegatta","year":"2022","journal-title":"J. Clin. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1080\/17434440.2016.1224644","article-title":"Insights into the definition of terms in European medical device regulation","volume":"13","author":"Racchi","year":"2016","journal-title":"Expert Rev. Med. Devices"},{"key":"B32","article-title":"Regulation (EU) 2017\/745 of the European parliament and of the Council of 5 april 2017 on medical devices, amending directive 2001\/83\/EC, regulation (EC) No 178\/2002 and regulation (EC) No 1223\/2009 and repealing Council directives 90\/385\/EEC and 93\/42\/EEC","year":"2017"},{"key":"B33","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/MEG.0000000000001888","article-title":"A randomized, double-blind, placebo-controlled pilot study to evaluate the efficacy and tolerability of a novel oral bioadhesive formulation for the treatment of nonerosive reflux disease-related symptoms","volume":"32","author":"Ribaldone","year":"2021","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e13132","DOI":"10.1111\/nmo.13132","article-title":"A randomized placebo-controlled trial on the effects of Menthacarin, a proprietary peppermint- and caraway-oil-preparation, on symptoms and quality of life in patients with functional dyspepsia","volume":"29","author":"Rich","year":"2017","journal-title":"Neurogastroenterol. Motil."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.1038\/ctg.2015.18","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of single rising TAK-438 (vonoprazan) doses in healthy male Japanese\/non-Japanese subjects","volume":"6","author":"Sakurai","year":"2015","journal-title":"Clin. Transl. Gastroenterol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/ajg.2011.90","article-title":"The role of Acid in functional dyspepsia","volume":"106","author":"Savarino","year":"2011","journal-title":"Am. J. Gastroenterol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00535-012-0672-2","article-title":"Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn","volume":"48","author":"Savarino","year":"2013","journal-title":"J. Gastroenterol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nrgastro.2013.50","article-title":"Nerd: An umbrella term including heterogeneous subpopulations","volume":"10","author":"Savarino","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1080\/17474124.2021.1984878","article-title":"An update of pharmacology, efficacy, and safety of vonoprazan in acid-related disorders","volume":"16","author":"Savarino","year":"2022","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.phrs.2008.09.016","article-title":"Proton pump inhibitors in GORD an overview of their pharmacology, efficacy and safety","volume":"59","author":"Savarino","year":"2009","journal-title":"Pharmacol. Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.dld.2020.10.003","article-title":"Esophageal reflux hypersensitivity: Non-GERD or still GERD?","volume":"52","author":"Savarino","year":"2020","journal-title":"Dig. Liver Dis."},{"key":"B42","first-page":"917","article-title":"Overnight comparable anacidity by standard large and half-single bedtime doses of H2 antagonists in duodenal ulcer patients: A clinical pharmacological study","volume":"83","author":"Savarino","year":"1988","journal-title":"Am. J. Gastroenterol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1046\/j.1365-2036.1998.00416.x","article-title":"Comparison of 24-h control of gastric acidity by three different dosages of pantoprazole in patients with duodenal ulcer","volume":"12","author":"Savarino","year":"1998","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B44","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/apt.13914","article-title":"Randomised clinical trial: Mucosal protection combined with acid suppression in the treatment of non-erosive reflux disease - efficacy of esoxx, a hyaluronic acid-chondroitin sulphate based bioadhesive formulation","volume":"45","author":"Savarino","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B45","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1586\/ecp.09.33","article-title":"Long lasting inhibitors of the gastric H,K-ATPase","volume":"2","author":"Shin","year":"2009","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3851\/IMP2975","article-title":"Hepatitis C cure with antiviral therapy--benefits beyond the liver","volume":"21","author":"Soriano","year":"2016","journal-title":"Antivir. Ther."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1053\/j.gastro.2016.02.011","article-title":"Gastroduodenal disorders","volume":"150","author":"Stanghellini","year":"2016","journal-title":"Gastroenterology"},{"key":"B48","doi-asserted-by":"publisher","first-page":"753938","DOI":"10.3389\/fped.2021.753938","article-title":"Promelaxin microenemas are non-inferior to oral polyethylene glycol for the treatment of functional constipation in young children: A randomized clinical trial","volume":"9","author":"Strisciuglio","year":"2021","journal-title":"Front. Pediatr."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1053\/j.gastro.2005.11.059","article-title":"Functional gastroduodenal disorders","volume":"130","author":"Tack","year":"2006","journal-title":"Gastroenterology"},{"key":"B50","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1365-2036.1991.tb00757.x","article-title":"Non-ulcer dyspepsia: Myths and realities","volume":"5","author":"Talley","year":"1991","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B51","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1056\/NEJM198901123200201","article-title":"Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer","volume":"320","author":"Walan","year":"1989","journal-title":"N. Engl. J. Med."}],"container-title":["Frontiers in Drug Safety and Regulation"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fdsfr.2023.1119353\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T09:47:15Z","timestamp":1768902435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fdsfr.2023.1119353\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,24]]},"references-count":51,"alternative-id":["10.3389\/fdsfr.2023.1119353"],"URL":"https:\/\/doi.org\/10.3389\/fdsfr.2023.1119353","relation":{},"ISSN":["2674-0869"],"issn-type":[{"value":"2674-0869","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,24]]},"article-number":"1119353"}}